Literature DB >> 22588322

Acute effect of percutaneous MitraClip therapy in patients with haemodynamic decompensation.

Simon Biner1, Robert J Siegel, Ted Feldman, Asim M Rafique, Alfredo Trento, Patrick Whitlow, Jason Rogers, Marc Moon, Brian Lindman, Alan Zajarias, Donald Glower, Saibal Kar.   

Abstract

AIMS: To evaluate the haemodynamic effect of acute procedural success (APS) after MitraClip therapy in patients with haemodynamic decompensation. METHODS AND
RESULTS: Of 107 patients, 79 achieved APS after MitraClip implantation. The increase in cardiac index (CI) was primarily detected in patients with a low baseline CI (2.0 ± 0.5 to 2.5 ± 5 L/min/m(2), P < 0.001). There was a decrease in left ventricular end-diastolic pressure (LVEDP) (20 ± 5 to 13 ± 5 mmHg, P = 0.002) and mean pulmonary capillary wedge pressure (PCWPm) (20 ± 4 to 16 ± 5 mmHg, P = 0.001) in patients with values >15 mmHg at baseline, and a decrease in mean pulmonary artery systolic (PAPm) (36 ± 4 to 29 ± 7 mmHg P = 0.003) in those with values >30 mmHg before the MitraClip procedure. Patients with decompensation compared with patients with compensation experienced significant reduction in LVEDP (-8.3 ± 11.9 mmHg vs. -0.2 ± 4.5 mmHg, P = 0.009), a reduction in PCWPm (-3.5 ± 5.6 mmHg vs. 1.9 ± 4.7 mmHg, P < 0.001), and a reduction in PAPm (-8 ± 9 mmHg vs. 3 ± 6 mmHg, P < 0.001).
CONCLUSION: The favourable haemodynamic effects of MitraClip therapy on CI were primarily detected in patients with low CI before the procedure, and improvements in left-sided filling pressure and PAP were primarily seen in those with elevated values at baseline.

Entities:  

Mesh:

Year:  2012        PMID: 22588322     DOI: 10.1093/eurjhf/hfs069

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  7 in total

Review 1.  Percutaneous edge-to-edge mitral valve repair. Current clinical evidence with the MitraClip System.

Authors:  R Estevez-Loureiro; O Franzen
Journal:  Herz       Date:  2013-08       Impact factor: 1.443

2.  [Evaluation of mitral regurgitation : How much quantification do we need?]

Authors:  F Kreidel; T Ruf; A Tamm; M Geyer; T Emrich; R S von Bardeleben
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

3.  Safety, Mortality, and Hemodynamic Impact of Patients with MitraClip Undergoing Left Ventricular Assist Device Implantation.

Authors:  Henrik Fox; Takayuki Gyoten; Sebastian V Rojas; Marcus-André Deutsch; René Schramm; Volker Rudolph; Jan F Gummert; Michiel Morshuis
Journal:  J Cardiovasc Transl Res       Date:  2021-10-28       Impact factor: 3.216

4.  Pulmonary Hemorrhage following Edge-to-Edge Mitral Valve Repair.

Authors:  Mirna B Ayache; Myttle A Mayuga; Chantal ElAmm; Guilherme Attizzani; Jordan Kazakov
Journal:  Case Rep Cardiol       Date:  2017-06-19

5.  Non invasive evaluation of cardiomechanics in patients undergoing MitrClip procedure.

Authors:  Fabio Guarracino; Baldassare Ferro; Rubia Baldassarri; Pietro Bertini; Francesco Forfori; Cristina Giannini; Vitantonio Di Bello; Anna S Petronio
Journal:  Cardiovasc Ultrasound       Date:  2013-05-04       Impact factor: 2.062

Review 6.  Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review.

Authors:  Kevin Bryan Lo; Sandeep Dayanand; Pradhum Ram; Pradeep Dayanand; Leandro N Slipczuk; Vincent M Figueredo; Janani Rangaswami
Journal:  Curr Cardiol Rev       Date:  2019

7.  Mitraclip insertion to hasten recovery from severe COVID-19 disease.

Authors:  Vinayak Nagaraja; Tom Kai Ming Wang; Serge C Harb; Samir R Kapadia
Journal:  CASE (Phila)       Date:  2020-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.